Avance Nerve Graft
Peripheral Nerve Repair (Broad)
Key Facts
About Axogen
Axogen's mission is to restore peripheral nerve function and quality of life by providing innovative, clinically proven repair solutions. The company has achieved commercial dominance in the surgical nerve repair market with its FDA-approved Avance® Nerve Graft, supported by a robust body of clinical evidence. Its strategy centers on deepening surgeon adoption, expanding into new surgical indications, and leveraging its direct commercial model to drive growth. Axogen represents a pure-play investment in the specialized and underserved field of peripheral nerve regeneration.
View full company profileAbout Axogen
Axogen's mission is to restore peripheral nerve function and quality of life by providing innovative, clinically proven repair solutions. The company has achieved commercial dominance in the surgical nerve repair market with its FDA-approved Avance® Nerve Graft, supported by a robust body of clinical evidence. Its strategy centers on deepening surgeon adoption, expanding into new surgical indications, and leveraging its direct commercial model to drive growth. Axogen represents a pure-play investment in the specialized and underserved field of peripheral nerve regeneration.
View full company profileAbout Axogen
Axogen's mission is to restore peripheral nerve function and quality of life by providing innovative, clinically proven repair solutions. The company has achieved commercial dominance in the surgical nerve repair market with its FDA-approved Avance® Nerve Graft, supported by a robust body of clinical evidence. Its strategy centers on deepening surgeon adoption, expanding into new surgical indications, and leveraging its direct commercial model to drive growth. Axogen represents a pure-play investment in the specialized and underserved field of peripheral nerve regeneration.
View full company profileAbout Axogen
Axogen's mission is to restore peripheral nerve function and quality of life by providing innovative, clinically proven repair solutions. The company has achieved commercial dominance in the surgical nerve repair market with its FDA-approved Avance® Nerve Graft, supported by a robust body of clinical evidence. Its strategy centers on deepening surgeon adoption, expanding into new surgical indications, and leveraging its direct commercial model to drive growth. Axogen represents a pure-play investment in the specialized and underserved field of peripheral nerve regeneration.
View full company profile